|
FDA?s New Endotoxin Test Guidance for Human Parenteral Drugs, Biologic
Wednesday
01.00 PM
http://c2gowebinars.com/product/?topic=endotoxin
10777 Westheimer Suite 1100, Houston, Texas, USA,
Houston Yukon Territory 77042
Report Abuse
|
|
DESCRIPTION
Topic Background:
FDA current thinking regarding Endotoxin testing has changed. Industry needs to adopt this new thinking in order to prevent observations, which lead to further scrutiny by the agency.
Description:
The current of the FDA regarding the use of the Limulus Amoebycyte Lysate (LAL) test for endotoxins in lieu of the rabbit pyrogens test is has changed. As a result, the last guidance document, Guideline on Validation of the Limulus Amedocyte Lysate (LAL) Test as an End-Product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products, and Medical Devices, which was published in 1987, has been withdrawn by the agency.
The FDA has found that the published USP and AAMI documents describing methods and calculation of pyrogen and endotoxins testing limits provide industry with appropriate information. There are continuing efforts to harmonize USP Chapters and and FDA guidance documents to reflect the current thinking of the agency. Until this harmonization is complete, the FDA is providing supplemental information in this guidance to explain the current thinking regarding submission and maintenance of pyrogen and endotoxins testing for FDA regulated products.
Why should you attend :
This guidance does not cover the entire subject of pyrogen and endotoxins testing. Instead, it addresses those issues that may be subject to misinterpretation and are not covered in compendial procedures or in currently available documents. There should already be a thorough understanding of these compendial references. The recommendations should be incorporated by organization in order to adopt the current thinking of the agency to prevent observations.
Key learning objectives of the Topic :
Provide a review of the current testing requirements
Understanding what happened to the old 87/91 LAL Guidance for Industry document
Learn what has replaced it and why
Learn of common issue misunderstandings and misinterpretations
Determine who comprised the Agency Guidance team involved with in this new proposed Guidance
Learn of the documents supporting this new Guidance
Learn about sampling, storage, handling and pooling
How does one transition from one bacterial endotoxin test to another?Understand the RPT (Rabbit Pyrogen Test).
Learn about the Monocyte Activation Test (MAT). Determine when the Rabbit Pyrogen Test is appropriate to use in lieu of the LAL.
Understand the FDA?s expectation for screening of therapeutic products.
Areas covered during the Session:
Background
Definitions
Examine the 1987 Guidance for Industry Document
Review Current Testing Requirements
Overview of New Guidance for Industry LAL
Examine the Bases for Bacterial Endotoxin Tests
Learn of the documents supporting the proposed, new FDA Guidance
Learn which specific Chapter is yet to be harmonized
Learn of the typical issues confronting the end user of LAL testing.
Warning Letter Examples
Who will benefit :
Senior Management
Regulatory Affairs management and personnel
Compliance Officer and personnel
Quality Assurance management and personnel
Research and Development
Validation
Auditing Management and professional
Quality Control management and professional
Webinar Includes:
Q/A Session with the Expert to ask your question
PDF print only copy of PowerPoint slides
90 Minutes Live Presentation
Certificate of Attendance
For?Registration?:http://c2gowebinars.com/product/?topic=endotoxin
Note:?Use?coupon?code????and?get?15% off?on?registration.
|
compliance2go
Phone: 8777824696
8777824696
Email: subscribe (at) compliance2go.com |
|
|
| Report Abuse |
|
|
| |
| |
|
| List your Event |
| | Similar Events | Barcelona: 11th International Conference on Epilepsy & Treatment
Welcome to The 11th International Conference on Epilepsy & Treatment which is going to be held during April 29-30,2025 is a significant event in the field of neurology and epilepsy care, set to take place in the culturally rich and vibrant city o
Date Posted: 04-Nov-24
| Barcelona: 11th International Conference on Epilepsy & Treatment
About Conference
Welcome to The 11th International Conference on Epilepsy & Treatment which is going to be held during April 29-30,2025 is a significant event in the field of neurology and epilepsy care, set to take place in the culturally r
Date Posted: 23-Nov-24
| Boston: 2 DAY SEMINAR Effective Compliance Strategies for Complaint Handling,
2 DAY SEMINAR Effective Compliance Strategies for Complaint Handling, Medical Device
Location 1: Boston,MA
Jul 11 - 12
Description
Complaint handling systems have come under intense scrutiny by the FDA in recent years and enforcement trends
Date Posted: 04-May-18
| FL: Live Webinar Understanding and Applying the New EU Medical Device Regu
Live Webinar Understanding and Applying the New EU Medical Device Regulations (EMDR)
Description
The European Parliament just adopted the Medical Devices (MDR) and In vitro Diagnostic Medical Devices (IVDR) regulations. The adoption
Date Posted: 26-Apr-18
| FL: 3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Exis
3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance
Description
A premarket notification (510(k)) is required when a legally marketed device subject to 510(k) requirements is about to be
Date Posted: 30-Apr-18
| FL: 3-hrs Webinar-Deciding When to Submit a 510(k)
3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance
Description
A premarket notification (510(k)) is required when a legally marketed device subject to 510(k) requirements is about to b
Date Posted: 11-May-18
| FL: 3-hrs Virtual Training 2018 Latest FDA thinking on deciding when
3-hrs Virtual Training 2018 Latest FDA thinking on deciding when to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance
Description
A premarket notification (510(k)) is required when a legally marketed device subject
Date Posted: 31-May-18
| Houston: 10 Days to HIPAA Compliance ? The 10 Step HIPAA Compliance Project
DESCRIPTION
The topic of HIPAA compliance will be covered in a format of ?10 Days to HIPAA Compliance? wherein focusing the work to be done according to 10 topic areas helps ensure the essential issues are considered. While compliance may take mo
Date Posted: 15-Apr-16
| FL: Live Webinar FDA’s Final Rule Regarding Device Establishment Registrat
Live Webinar FDA’s Final Rule Regarding Device Establishment Registration and Listing: Procedure on How to Register and List
Description
Device firms, establishments or facilities that are involved in the production and distribution of medica
Date Posted: 08-May-18
| FL: 3 Hours Webinar on HR Auditing: Identifying and Managing Key Risks
3 Hours Webinar on HR Auditing: Identifying and Managing Key Risks
Description
HR audits are designed to help your organization focus its attention on its human resource management practices, policies, procedures, processes, and outcomes by prov
Date Posted: 30-Apr-18
| FL: Live Webinar FDA’s Final Rule Regarding Device Establishment Registrat
Live Webinar FDA’s Final Rule Regarding Device Establishment Registration and Listing: Procedure on How to Register and List
Description
Device firms, establishments or facilities that are involved in the production and distribution of me
Date Posted: 27-Apr-18
| FL: Live Webinar Construct and Manage the Technical File and Design Dossie
Live Webinar Construct and Manage the Technical File and Design Dossier
Description
This Webinar will provide a substantive overview and outline differences between the Technical File and Design Dossier for those device firms dealing with the glo
Date Posted: 30-Apr-18
| Houston: Mobile Devices and HIPAA ? Managing Risks and Improving Productivity
DESCRIPTION
This session will review the requirements and current issues pertaining to mobile devices and present ways for the attendees to consider how to meet patient desires and stay within the regulations, including processes for managing port
Date Posted: 18-Apr-16
| Barcelona: 11th International Conference on Epilepsy &Treatment April 29-30, 2025
Welcome to The 11th International Conference on Epilepsy & Treatment which is going to be held during April 29-30,2025 is a significant event in the field of neurology and epilepsy care, set to take place in the culturally rich and vibrant city o
Date Posted: 25-Oct-24
| FL: Live Webinar Texting, E-mail, and Mobile Devices: Using Modern Communi
Live Webinar Texting, E-mail, and Mobile Devices: Using Modern Communications According to HIPAA by Jim Sheldon-Dean
Description
Over the last few years, a revolution in personal communications has occurred, and the widespread adoption of mobil
Date Posted: 02-May-18
|
|
Map locations are shown as per geocoding services and they depeneds on the accuracy of the address. If address is wrong it may show wrong map. If you put a listing which shows wrong map, please remove the listing and create a new one with correct address details.
Please note: The information on this site is submitted by users. CanadianDesi never checks accuracy of the information. Please use this information at your risk. If you have any question or concern regarding this listing, or you know that the above information is not accurate, please Contact Us. Thanks.
|
| Please note: The information on this site is submitted by users. CanadianDesi never checks accuracy of the information. Please use this information at your risk. If you have any question or concern regarding this listing, or you know that the above information is not accurate, please Contact Us. Thanks.
|
|
